Search

Displaying results 5011 - 5020 of 6076 in total
  1. Drug

    Taberminogene vadenovec

    go.drugbank.com/drugs/DB05011
    Experimental

    EG004 has completed a Phase II trial, this being the first part of the Phase II/III study for which it has received approval from the US Recombinant DNA Advisory Committee (RAC).

  2. Drug

    Ilaprazole

    go.drugbank.com/drugs/DB11964
    Investigational

    Ilaprazole has been investigated in Helicobacter Infections.

    Categories: Drugs for Acid Related Disorders, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
  3. Drug

    Morphine glucuronide

    go.drugbank.com/drugs/DB06409
    Investigational

  4. Drug

    Perospirone

    go.drugbank.com/drugs/DB08922
    Investigational

    Dainippon Sumitomo Pharma developed perospirone in Japan in 2001 for the treatment of acute schizophrenia and bipolar mania as well as chronic schizophrenia.

  5. Drug

    Fenoverine

    go.drugbank.com/drugs/DB13042
    Investigational

    Fenoverine has been used in trials studying the treatment of Irritable Bowel Syndrome.

    Categories: Drugs for Functional Gastrointestinal Disorders
  6. Drug

    Acefylline

    go.drugbank.com/drugs/DB13573
    Experimental

    Categories: Drugs for Obstructive Airway Diseases
  7. Drug

    Pipenzolate

    go.drugbank.com/drugs/DB13844
    Investigational

    Categories: Drugs for Functional Gastrointestinal Disorders
  8. Drug

    Plozalizumab

    go.drugbank.com/drugs/DB12520
    Investigational

    Plozalizumab has been investigated for the treatment of Atherosclerosis.

  9. Drug

    Mesterolone

    go.drugbank.com/drugs/DB13587
    Investigational

    It is not a substrate for aromatase so it is not converted into estrogen. Mesterolone demonstrated to have minimal effect on sperm counts and levels of FSH or LH [A27177, A27178].

  10. Drug

    2-deoxyglucose

    go.drugbank.com/drugs/DB08831
    Investigational

    Although there are several possible therapeutic indications for 2-deoxyglucose, presently there is no approved indication for 2-deoxyglucose as a therapeutic agent.